CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Oxycodone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 10 USDMF, 10 CEP/COS, 1 JDMF, 1 EU WC, 7 KDMF, 14 NDC API, 16 Listed Suppliers

DEVELOPMENTS

81 Drugs in Development

81 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1175 FDF Dossiers, 293 FDA Orange Book, 673 Europe, 49 Canada, 88 Australia, 21 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 5MG, SOLUTION;ORAL - 100MG/5ML, SOLUTION;ORAL - 5MG/5ML, SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG, TABLET;ORAL - 7.5MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 18MG, CAPSULE, EXTENDED RELEASE;ORAL - 27MG, CAPSULE, EXTENDED RELEASE;ORAL - 36MG, CAPSULE, EXTENDED RELEASE;ORAL - 9MG, TABLET, EXTENDED RELEASE;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 20MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 80MG, TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 15 Evonik, 7 Rochem International Inc, 23 SPI Pharma, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 8 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 7 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 14 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 38 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 1 Clariant, 22 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 1 Gloria Interchem, 10 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 2 Nanjing Bold Chemical, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 78 Coating Systems & Additives, 56 Controlled & Modified Release, 46 Direct Compression, 45 Taste Masking, 44 Disintegrants & Superdisintegrants, 43 Thickeners and Stabilizers, 41 Granulation, 35 Solubilizers, 33 Film Formers & Plasticizers, 32 Parenteral, 26 Lubricants & Glidants, 25 Chewable & Orodispersible Aids, 25 Topical, 18 Co-Processed Excipients, 14 API Stability Enhancers, 10 Emulsifying Agents, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

297 News #PharmaBuzz

297 News #PharmaBuzz

GLOBAL SALES INFORMATION

59 US Medicaid Prescriptions, 87 Regulatory FDF Prices, 20 Annual Reports

MARKET PLACE

13 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

168 US Patents, 71 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 7 Others

Xls

Filters

Supplier	Contact Email	Supplier's Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
Veranova	info@veranova.com	https://www.pharmacompass.com/pharma-services/api-manufacturing-services/veranova	U.S.A	Nosa Chemical Co., Ltd.	20191223-209-J-267(2)	Oxycodone hydrochloride	2019-12-23	Macfarlan Smith Ltd.	United Kingdom	10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Noramco	aambrosi@Noramco.com	https://www.pharmacompass.com/api-manufacturers/noramco	U.S.A	Samung Industry Co., Ltd.	20240126-209-J-1599	Oxycodone hydrochloride	2024-01-26	Noramco, LLC	U.S.A	500 Swedes Landing Road Wilmington, Delaware 19801

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Oxycodone

Oxycodone

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

10 USDMF

10 CEP/COS

1 JDMF

1 EU WC

7 KDMF

14 NDC API

16 Listed Suppliers

DEVELOPMENTS

81 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1175 FDF Dossiers

293 FDA Orange Book

673 Europe

49 Canada

88 Australia

21 South Africa

51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 5MG

SOLUTION;ORAL - 100MG/5ML

SOLUTION;ORAL - 5MG/5ML

SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG

TABLET;ORAL - 7.5MG

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG

CAPSULE, EXTENDED RELEASE;ORAL - 18MG

CAPSULE, EXTENDED RELEASE;ORAL - 27MG

CAPSULE, EXTENDED RELEASE;ORAL - 36MG

CAPSULE, EXTENDED RELEASE;ORAL - 9MG

TABLET, EXTENDED RELEASE;ORAL - 10MG

TABLET, EXTENDED RELEASE;ORAL - 15MG

TABLET, EXTENDED RELEASE;ORAL - 20MG

TABLET, EXTENDED RELEASE;ORAL - 30MG

TABLET, EXTENDED RELEASE;ORAL - 40MG

TABLET, EXTENDED RELEASE;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 80MG

TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

15 Evonik

7 Rochem International Inc

23 SPI Pharma

2 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Pfanstiehl

8 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

7 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

14 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

38 BASF

1 Bioplus Life Sciences

3 CD Formulation

1 Clariant

22 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

1 Gloria Interchem

10 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

SOLUTION;ORAL - 5MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 325MG;5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons